Header cover image

Integration With ADNOC And ExxonMobil Will Position As World’S Largest Low-Carbon Ammonia Producer

WA
Consensus Narrative from 10 Analysts

Published

February 09 2025

Updated

February 09 2025

Key Takeaways

  • Fertiglobe's strategic focus on low-carbon ammonia expansion positions it for significant earnings growth and market leadership.
  • Collaboration with ADNOC and cost optimizations enhance financial stability and potential future profitability.
  • Fertiglobe's financial stability faces risks from uncertain gas pricing, production disruptions, delayed projects, market volatility, and competitive pressures in global markets.

Catalysts

About Fertiglobe
    Produces and sells nitrogen-based products worldwide.
What are the underlying business or industry changes driving this perspective?
  • Fertiglobe's integration of ADNOC's low-carbon ammonia initiatives and transfer of equity stakes in multiple projects, including the U.S. project with ExxonMobil, positions the company as a major low-carbon ammonia growth platform, which is expected to significantly boost future earnings.
  • The expected doubling of Fertiglobe's low-carbon ammonia capacity to 4 million tons by 2029 will increase its total product capacity, potentially driving revenue growth and enhancing market position as the world's largest low-carbon ammonia producer.
  • The company's ongoing manufacturing improvement plan and cost optimization targets are projected to add up to $150 million in annual EBITDA by the end of 2025, which should improve net margins.
  • Supportive regulations and rising carbon costs in Europe are anticipated to elevate global ammonia prices, benefiting Fertiglobe's revenue and profit margins due to its focus on low-carbon ammonia.
  • Fertiglobe's strategic alliance with ADNOC, focusing on cost and operational synergies, while leveraging ADNOC’s resources, enhances Fertiglobe's financial stability and capacity to implement selective growth projects, potentially bolstering earnings and free cash flow.

Fertiglobe Earnings and Revenue Growth

Fertiglobe Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Fertiglobe's revenue will grow by 2.4% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 9.8% today to 10.0% in 3 years time.
  • Analysts expect earnings to reach $235.4 million (and earnings per share of $0.03) by about February 2028, up from $214.7 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as $366.3 million.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 49.6x on those 2028 earnings, up from 25.6x today. This future PE is greater than the current PE for the AE Chemicals industry at 21.3x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 19.96%, as per the Simply Wall St company report.

Fertiglobe Future Earnings Per Share Growth

Fertiglobe Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • The ongoing negotiations and uncertainty around Sorfert's gas pricing setup in Algeria could influence Fertiglobe's net profit and revenue projections, as historical pricing mechanisms have expired, leading to financial provisions and potential fluctuations in cash flow.
  • External factors, such as gas supply issues in Egypt and power shortages in Algeria, have already resulted in lower production volumes, which might continue impacting revenue and net margins if such disruptions persist.
  • Delays in finalizing the Final Investment Decision (FID) for the ExxonMobil Baytown project in the U.S. could influence the timeline and costs associated with expected capacity expansions, thereby affecting future revenue and earnings growth potential.
  • Market volatility and uncontrollable external events have historically impacted Fertiglobe's performance, as seen with declining revenue and EBITDA year-over-year, indicating potential risks to the stability of net profit and cash flows.
  • Fertiglobe faces competitive pressures and potential oversupply risks in the global ammonia and fertilizer markets, which could impact market prices and, hence, revenue potential amid tight margins and reliance on market demand dynamics.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of AED2.992 for Fertiglobe based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of AED3.4, and the most bearish reporting a price target of just AED2.48.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $2.4 billion, earnings will come to $235.4 million, and it would be trading on a PE ratio of 49.6x, assuming you use a discount rate of 20.0%.
  • Given the current share price of AED2.43, the analyst price target of AED2.99 is 18.8% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

Warren A.I. is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by Warren A.I. are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that Warren A.I.'s analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value
د.إ3.0
18.1% undervalued intrinsic discount
Analyst Price Target Fair Value
Future estimation in
PastFuture05b2018202020222024202520262028Revenue US$2.4bEarnings US$235.4m
% p.a.
Decrease
Increase
Current revenue growth rate
5.14%
Chemicals revenue growth rate
1.31%